A Phase 4 interventional study of Fixed 50:50 mixture of nitrous oxide and oxygen and Placebo in Pain and Anxiety, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University Hospital, Clermont-Ferrand · Phase 4, Interventional, and Treatment
Nicot M, Miraillet L, Pereira B, Bouillon-Minois JB, Raconnat J, Moustafa F, Schmidt J, Sickout-Arondo S, Bernard L, Clavelou P, Moisset X. The Use of a Fixed…PubMed 35329815 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 45 studies in Pain by University Hospital, Clermont-Ferrand — 8 open to participants now, 8 under way, 1 of them phase 3. Pain · University Hospital, Clermont-Ferrand.
Among the 45 studies in Pain by University Hospital, Clermont-Ferrand, this one is the 16th largest by enrollment of the 31 interventional ones that give a count, is the only one that started in 2019, is one of 6 in phase 4, and was the 27th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →8 of the 45 studies in Pain by University Hospital, Clermont-Ferrand are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Clermont-Ferrand · Sites in France
Ages 18+
University Hospital, Clermont-Ferrand · Sites in France
Ages 18–50 · Women only · Healthy volunteers
University Hospital, Clermont-Ferrand · Sites in France
Ages 18+
University Hospital, Clermont-Ferrand · Sites in France
Ages 18+
University Hospital, Clermont-Ferrand
Ages 18+
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
45 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 1 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 88 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 88 across the 31 interventional studies, 230 across the 14 observational. Of the 27 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 177 are open to participants now.
6 of the studies in Pain by University Hospital, Clermont-Ferrand that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06917651Phase 3University Hospital, Clermont-FerrandManagement of Moderate to Severe Monotraumatic Pain With Sublingual Sufentanil in an Emergency Situation. | 2027-04-22 |
| NCT07668050University Hospital, Clermont-FerrandA Study of the Impact of a Virtual Reality Medical Device (HypnoVR® Headset) on Anxiety and Pain in Interventional Radiology. | 2026-12 |
| NCT06813326University Hospital, Clermont-FerrandInterest of Nurse Participation During Epicutaneous-cavity Catheter Placement in Neonatal Intensive Care | 2027-02-04 |
| NCT06426316University Hospital, Clermont-FerrandThe Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology. | 2027-04-30 |
| NCT07679087University Hospital, Clermont-FerrandStudy of the Frequency and Characteristics of Pain Symptoms in Restless Legs Syndrome | 2027-08 |
Add all 6 to your calendar (.ics) → With an account.
Among the 45 studies in Pain by University Hospital, Clermont-Ferrand, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Lumbar puncture (LP) is a frequent exam that can cause pain and anxiety. In a scheduled setting, it has been shown that nitrous oxide use during the procedure was able to reduce both pain and anxiety. The goal of this trial is to confirm these results in a more heterogeneous group of patients having a LP, in an emergency setting.
Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a century. Nonetheless, it's use during lumbar puncture in adults has only been investigated in a scheduled setting.Thus, this study is designed to evaluate the analgesic effect of N2O on the pain induced during lumbar puncture.
Patients with urgent lumbar puncture realized for diagnosis purposes will be randomized in 2 groups. One group will inhale N2O for the 5 minutes before the puncture and during the rest of the procedure. The second group will inhale compressed air during the same period. Neither the investigator realizing the lumbar puncture, nor the patient will know which type of gaz they are inhaling (double-blinding).
The maximal pain level that occurred during the procedure will be evaluated on a Numerical Rating Scale (NRS). NRS will also be used to evaluate the maximal anxiety induced by the procedure.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
will inhale experimental treatment throughout the entire procedure (50% N2O - 50% 02)
Drug: Fixed 50:50 mixture of nitrous oxide and oxygen
will inhale medical air throughout the entire procedure (22% O2 + N2 Q.S.)
Other: Placebo
Gaz inhalation will start 5 minutes before the puncture and will be continued until the end of the procedure.
inhale medical air (22% O2 - 78% N2)
Maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale
Maximal level of pain during lumbar puncture. The patient will be asked to circle the digit that best describes the maximal level of pain felt during the procedure. If the patient is too painful and/or is incapacitated, the collection notebook will be fulfilled by the care provider after asking the following question: "On a scale of 0 to 10, 0 being the absence of pain and 10 the maximal pain you can imagine, what is the digit best describing the maximal pain you felt during the procedure?"
Time frame: 2-3 minutes after the end of gas inhalation
Maximal anxiety perceived during lumbar puncture evaluated using a simple numeric 0-10 scale
Proportion of patients with significant anxiety
Time frame: 2-3 minutes after the end of gas inhalation
Side effects
Every side effect reported by the patients attributable to gas inhalation during the procedure up to emergency service discharge. Presence, intensity and reversibility will be recorded
Time frame: From the beginning of gas inhalation to a minimum of 2 hours later
Spinal puncture duration
Comparison of LP duration between both groups measured in minutes (from the beginning of gas inhalation to needle removal).
Time frame: 2-3 minutes after the end of lumbar puncture
Number of attempts before successful LP
Comparison of number of attempts needed to get spinal fluid, defined as number of needle removals for a single exam.
Time frame: 2-3 minutes after the end of lumbar puncture
Patient Satisfaction
overall satisfaction based on a 0-10 score and proportion of patients that would accept another lumbar puncture in the same conditions
Time frame: 2-3 minutes after the end of gas inhalation
Blinding quality
Assessment of blinding in clinical trials (according to Bang et al. 2004)
Time frame: 2-3 minutes after the end of gas inhalation
Induced cost
supplementary cost induced by the use of nitrous oxide inhalation for a total of 88 patients throughout the study (gas and consumables such as masks and pipes)
Time frame: through study completion, an average 4 months
Plan to share: Undecided
Ran from Nov 2019 to primary completion in Oct 2020, 10 months.
Of 280 non-industry phase 4 interventional studies under Pain, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 35. This study's 10 months is below that.
Counting every sponsor, half of 295 studies reached it within 18 months; a quarter within 8 and three quarters within 33.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Apr 2020 → Oct 2020 and completion Sep 2020 → Oct 2020.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Nicot M, Miraillet L, Pereira B, Bouillon-Minois JB, Raconnat J, Moustafa F, Schmidt J, Sickout-Arondo S, Bernard L, Clavelou P, Moisset X. The Use of a Fixed…PubMed 35329815 ↗
Nicot M, Miraillet L, Pereira B, Bouillon-Minois JB, Raconnat J, Moustafa F, Schmidt J, Sickout-Arondo S, Bernard L, Clavelou P, Moisset X. The Use of a Fixed…PubMed 35329815 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand →